Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 21.10 billion as of April 28, 2026. Its market cap has decreased by -29.80% in one year.

Market Cap

21.10B

Enterprise Value

20.32B

Revenue

35.83M

Ranking

n/a

PE Ratio

n/a

Stock Price

138.50

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 21.10B, an increase of 391.35%. That is a compound annual growth rate of 15.90%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	21.10B	-35.59%
Dec 31, 2025	32.77B	-22.40%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sunmax Biotechnology	21.21B
Oneness Biotech	24.25B
AP Biosciences	16.73B
Medigen Vaccine Biologics	15.78B
Polaris Group	15.01B
EirGenix	13.80B
TaiMed Biologics	13.20B
Lin BioScience	34.74B

Market Cap Rankings